Spatial Metabolomics in Cancer: Mapping Metabolic Landscapes to Advance Precision Oncology

 

Spatial Metabolomics in Cancer: Mapping Metabolic Landscapes for Precision Oncology

Introduction

Cancer is not a uniform disease. Even within a single tumor, different regions can contain cancer cells, immune cells, fibroblasts, blood vessels, extracellular matrix, and other components of the tumor microenvironment. These regions can differ substantially in nutrient availability, oxygen levels, metabolic activity, immune signaling, and response to treatment.

Traditional metabolomics has provided important information about how cancer changes metabolism. However, conventional approaches often analyze metabolites from a mixed biological sample and therefore may lose information about where specific metabolic changes occur within a tumor.

Spatial metabolomics in cancer addresses this challenge by combining metabolomics with spatial information. Instead of simply asking which metabolites are present, spatial metabolomics asks where those metabolites are located and how their distribution relates to tumor architecture, cellular populations, and disease biology.

Mass spectrometry imaging (MSI), including approaches such as MALDI and DESI, has become an important technology for visualizing metabolite distributions directly within tissue. Research has demonstrated the ability of spatial metabolomics to investigate tumor heterogeneity, cancer-cell plasticity, metabolic interactions within the tumor microenvironment, and potential biomarkers.

As spatial technologies continue to develop, spatial metabolomics is becoming an important component of modern cancer research and may contribute to the development of more detailed biological maps for precision oncology.

 

What Is Spatial Metabolomics?

Spatial metabolomics is an approach used to study the distribution of metabolites across biological tissues while preserving their spatial context.

Metabolites are small molecules involved in energy production, biosynthesis, signaling, redox regulation, and many other biological processes. Examples include:

• Glucose
• Lactate
• Amino acids
• Fatty acids
• Lipids
• Nucleotides
• Organic acids
• Polyamines
• Steroid metabolites
• Other signaling and metabolic intermediates

Traditional metabolomics can measure the abundance of many metabolites in samples such as blood, urine, cell cultures, or tissue extracts. However, when an entire tumor is homogenized, spatial information is largely lost.

Spatial metabolomics attempts to preserve that information.

For example, instead of simply measuring elevated lactate in a tumor, spatial metabolomics can help researchers investigate whether lactate is particularly concentrated around hypoxic regions, specific tumor compartments, stromal cells, or immune-cell-rich areas.

This distinction is important because metabolic behavior can vary significantly from one region of a tumor to another.

 

Why Metabolism Matters in Cancer

Cancer cells frequently undergo metabolic changes that support proliferation, survival, adaptation, and interaction with surrounding cells.

Malignant cells may alter how they use glucose, amino acids, lipids, and other nutrients. At the same time, stromal and immune cells within the tumor microenvironment can also modify their metabolic programs.

The result is a complex metabolic ecosystem.

A 2026 review in Nature Reviews Cancer highlights the importance of understanding cancer metabolism across different biological scales, including cancer cells, neighboring stromal cells, and distant tissues. It also emphasizes that the nutrients supporting tumors can vary according to cancer type and anatomical location.

Spatial metabolomics adds another dimension to this field by helping researchers understand where metabolic processes occur.

This can reveal metabolic niches that may not be visible through bulk metabolomics alone.

 

Spatial Metabolomics vs Conventional Metabolomics

Both conventional metabolomics and spatial metabolomics examine metabolites, but their approaches are different.

Conventional Metabolomics

Conventional metabolomics generally provides information about the abundance or composition of metabolites in a biological sample.

For example:

Tumor sample → extraction → metabolite analysis → metabolic profile

This can provide valuable information about overall metabolic changes.

Spatial Metabolomics

Spatial metabolomics preserves tissue organization and connects molecular measurements with tissue location.

A simplified workflow is:

Tumor tissue → spatial measurement → metabolite mapping → metabolic landscape

This makes it possible to investigate whether certain metabolites are concentrated in particular tumor regions.

The spatial information can then be compared with histology, molecular features, immune-cell distribution, or other omics data.

 

How Spatial Metabolomics Works

Several technologies can contribute to spatial metabolomics, but mass spectrometry imaging is particularly important.

The general process involves several stages.

1. Tissue Collection

Tumor tissue is collected and preserved using a method appropriate for the analytical platform.

Sample handling is extremely important because metabolites can change during tissue collection, storage, and preparation.

2. Tissue Preparation

The tissue is sectioned and prepared for spatial analysis.

Researchers must balance preservation of tissue architecture with preservation of molecular information.

3. Molecular Ionization

Mass spectrometry imaging technologies ionize molecules from defined locations within the tissue.

4. Mass Spectrometric Detection

The resulting molecular ions are analyzed according to their mass-to-charge characteristics.

5. Spatial Mapping

Measurements collected from different locations are reconstructed into molecular images.

The final result can show the distribution of selected metabolites across the tissue.

6. Computational Analysis

Bioinformatics and statistical methods are used to identify spatial patterns, metabolic regions, molecular signatures, and relationships between metabolites.

MSI can directly visualize metabolite distributions in tissue and has been used to study cancer-associated biochemical changes and potential biomarkers.

 

Mass Spectrometry Imaging in Cancer Research

Mass spectrometry imaging has become an important platform for spatial molecular analysis.

Two widely discussed approaches are:

MALDI-MSI

Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI-MSI) uses a laser to analyze molecules from tissue surfaces following application of an appropriate matrix.

MALDI-based approaches can generate detailed molecular maps while preserving tissue location.

DESI-MSI

Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI) uses charged droplets to extract and ionize molecules from tissue surfaces.

MALDI and DESI can provide complementary approaches to spatial metabolite analysis. Research has shown their utility for investigating tumor heterogeneity, cancer-cell plasticity, and metabolic communication within the tumor microenvironment.

 

Mapping Metabolic Heterogeneity Within Tumors

One of the most important applications of spatial metabolomics is studying metabolic heterogeneity.

A tumor can contain multiple regions with different biological characteristics.

For example, one region may have:

• High glucose utilization
• Increased lactate production
• Low oxygen availability
• Strong hypoxia-associated signaling

Another region may have:

• Greater access to nutrients
• Increased immune-cell infiltration
• Different lipid metabolism
• Different proliferative activity

These differences can influence tumor progression and treatment response.

Spatial metabolomics allows researchers to examine such differences in relation to tissue architecture rather than treating the entire tumor as a single metabolic unit.

 

Tumor Microenvironment and Metabolic Communication

The tumor microenvironment is composed of many interacting cell types.

These include:

• Cancer cells
• T cells
• B cells
• Macrophages
• Dendritic cells
• Cancer-associated fibroblasts
• Endothelial cells
• Pericytes
• Other stromal populations

These cells compete for nutrients and can also exchange metabolic products.

Recent spatial and single-cell studies are increasingly revealing how metabolic interactions between tumor and stromal populations contribute to tumor biology. For example, research in hepatocellular carcinoma has used spatial multi-omics and single-cell mass spectrometry imaging to examine metabolic interactions involving cancer cells, cancer-associated fibroblasts, and macrophages.

This type of research may help explain why apparently similar tumor regions can have very different immune or therapeutic characteristics.

 

Cancer Cells and Nutrient Competition

Cancer cells require nutrients to support rapid growth and survival.

However, nutrients within tumors are not distributed uniformly.

Competition may occur for:

• Glucose
• Glutamine
• Lipids
• Amino acids
• Oxygen
• Other metabolic substrates

Metabolic competition can influence immune-cell function.

For example, immune cells operating within nutrient-depleted tumor regions may encounter a very different metabolic environment from immune cells in surrounding normal tissue.

Spatial metabolomics provides an opportunity to map these biochemical differences and investigate their relationship with cellular behavior.

 

Metabolic Niches Within Tumors

A metabolic niche can be considered a region within a tumor characterized by a particular combination of metabolites, cellular populations, and environmental conditions.

Potential metabolic niches may be associated with:

• Hypoxia
• Necrosis
• High proliferation
• Immune infiltration
• Stromal activity
• Blood-vessel proximity
• Invasive tumor margins
• Metastatic regions

Identifying these niches may improve understanding of how tumors organize themselves at the molecular level.

This is particularly important because treatment response may depend not only on the characteristics of cancer cells but also on the surrounding biochemical environment.

 

Spatial Metabolomics and Cancer Biomarkers

Cancer biomarkers can provide information about disease presence, prognosis, treatment response, or biological characteristics.

Spatial metabolomics may contribute to biomarker discovery by identifying metabolites or metabolic patterns associated with specific tissue regions.

Instead of looking only for a metabolite that is elevated throughout a tumor, researchers can ask:

• Is the metabolite concentrated in invasive regions?
• Is it associated with immune-suppressed areas?
• Does it occur near blood vessels?
• Is it enriched in treatment-resistant regions?
• Does it distinguish tumor from surrounding tissue?
• Does its distribution correlate with clinical outcomes?

These questions may help move biomarker research toward more spatially informed approaches.

However, discovery of a spatial metabolic signature does not automatically make it a clinically validated biomarker. Independent validation, standardized analytical procedures, reproducibility, and clinical studies remain necessary.

 

Spatial Metabolomics and Drug Resistance

Cancer treatment resistance is influenced by genetic, epigenetic, cellular, immune, and metabolic mechanisms.

Metabolic adaptation can allow cancer cells to survive under conditions created by therapy.

Spatial metabolomics may help researchers identify metabolic regions associated with resistant disease.

For example, treatment may alter:

• Glucose metabolism
• Lipid metabolism
• Amino-acid utilization
• Redox balance
• Energy production
• Metabolic signaling

Mapping these changes could provide clues about how tumor regions adapt during treatment.

Future studies may combine spatial metabolic profiles with treatment histories to investigate whether specific metabolic niches are associated with recurrence or resistance.

 

Spatial Metabolomics in Immuno-Oncology

The immune response within a tumor is strongly influenced by the local microenvironment.

Immune cells require energy and nutrients to maintain their functions. Cancer cells and stromal cells can modify the availability of those nutrients.

Consequently, metabolic conditions can influence:

• T-cell activity
• Macrophage behavior
• Immune suppression
• Cytokine signaling
• Antigen presentation
• Tumor-immune interactions

Spatial metabolomics can help researchers investigate these relationships directly within tissue.

When combined with spatial transcriptomics, spatial proteomics, and immune profiling, metabolic maps may provide a more comprehensive picture of how tumor cells and immune cells interact.

 

Spatial Metabolomics Across Cancer Types

Spatial metabolomics can potentially be applied across many cancer types.

Research areas include:

Breast Cancer

Spatial metabolic analysis may help investigate metabolic heterogeneity, tumor margins, and interactions between malignant and stromal compartments.

Prostate Cancer

Spatial metabolomics has been investigated for characterizing metabolic alterations within prostate tumor tissue and identifying spatially distinct molecular patterns.

Colorectal Cancer

Spatial metabolic mapping may help investigate differences between tumor regions, invasive margins, and surrounding tissue.

Liver Cancer

Hepatocellular carcinoma provides an important model for studying metabolic communication among cancer cells, fibroblasts, macrophages, and other components of the tumor microenvironment.

Brain Tumors

Metabolic imaging can provide information about molecular differences between tumor regions and surrounding brain tissue.

Lung Cancer

Spatial metabolic approaches may help characterize tumor heterogeneity and relationships between cancer cells, immune populations, and stromal compartments.

The most useful applications will depend on the cancer type, tissue characteristics, analytical platform, and clinical question.

 

Integrating Spatial Metabolomics With Spatial Transcriptomics

Spatial transcriptomics measures gene-expression patterns while preserving spatial information.

Spatial metabolomics measures the distribution of metabolites.

These technologies answer different biological questions.

Spatial Transcriptomics

What genes are being expressed, and where?

Spatial Metabolomics

What metabolites are present, and where?

Combining these datasets can connect gene regulation with metabolic activity.

For example, researchers could investigate whether a metabolic region is associated with the expression of genes involved in glycolysis, lipid metabolism, oxidative phosphorylation, amino-acid metabolism, or stress responses.

Spatial transcriptomics is increasingly being used to investigate tumor heterogeneity, tumor-microenvironment organization, drug resistance, and treatment response.

 

Integrating Spatial Metabolomics With Spatial Proteomics

Proteins represent another important layer of cancer biology.

Spatial proteomics can help identify:

• Signaling proteins
• Receptors
• Enzymes
• Immune markers
• Structural proteins
• Therapeutic targets

Spatial metabolomics can add information about the biochemical consequences of cellular activity.

Together, these approaches can help connect:

Genes → Proteins → Metabolic activity

Such integration could provide a more functional understanding of tumor biology.

 

Multi-Omic Spatial Cancer Mapping

The future of spatial cancer research is increasingly moving toward multi-omics.

A tumor can be investigated through multiple molecular layers:

• Genomics
• Epigenomics
• Transcriptomics
• Proteomics
• Metabolomics
• Lipidomics
• Imaging
• Histopathology

When these datasets are integrated spatially, researchers can begin constructing detailed molecular maps of tumors.

Recent research has highlighted the value of combining spatial and single-cell approaches to understand tumor biology and the complexity of the tumor microenvironment.

Three-dimensional spatial multi-omics is also emerging as an important direction for building more comprehensive tumor atlases.

 

Artificial Intelligence and Spatial Metabolomics

Spatial metabolomics can generate large and complex datasets.

Artificial intelligence and machine learning may help researchers analyze these datasets by identifying patterns that are difficult to detect manually.

Potential applications include:

• Spatial pattern recognition
• Metabolic-region classification
• Biomarker discovery
• Tumor-region segmentation
• Image analysis
• Metabolite classification
• Multi-omics integration
• Treatment-response prediction

AI-driven multi-omics integration is increasingly being explored in precision oncology to connect complex molecular datasets with actionable biological information.

However, AI models require high-quality data, appropriate validation, standardized workflows, and clinically relevant datasets before they can be translated into routine medical practice.

 

Applications in Precision Oncology

Precision oncology aims to match cancer treatment and management strategies with the biological characteristics of individual tumors.

Spatial metabolomics could contribute to this goal in several ways.

1. Biomarker Discovery

Spatial metabolic signatures could help identify molecular characteristics associated with disease or treatment response.

2. Tumor Classification

Metabolic patterns may help distinguish biologically different tumor regions or subtypes.

3. Treatment-Response Research

Researchers can compare metabolic landscapes before and after treatment.

4. Drug Resistance Research

Metabolic niches associated with resistant tumor populations can be investigated.

5. Immunotherapy Research

Spatial metabolic conditions can be studied alongside immune-cell distribution.

6. Surgical Applications

Spatial molecular imaging is being investigated as a potential rapid pathology-related tool during cancer surgery, although further development and validation are needed before broad routine clinical adoption.

 

Challenges and Limitations

Despite its potential, spatial metabolomics remains an evolving research technology.

Technical Complexity

Spatial metabolomics requires specialized instruments, tissue preparation protocols, computational workflows, and experienced researchers.

Metabolite Identification

Some molecular signals can be difficult to assign confidently to specific metabolites without additional validation.

Spatial Resolution

Different platforms provide different levels of spatial resolution.

Researchers must consider whether the resolution is sufficient for the biological question being investigated.

Sample Preparation

Metabolites can be sensitive to tissue handling, storage, temperature, and preparation conditions.

Data Complexity

Spatial metabolomics generates large datasets that require sophisticated computational analysis.

Standardization

Differences between laboratories in tissue preparation, instrumentation, data processing, and metabolite annotation can affect reproducibility.

Clinical Validation

A promising spatial metabolic signature must undergo rigorous validation before it can become a clinically useful diagnostic, prognostic, or predictive biomarker.

These challenges are consistent with broader issues facing spatial omics as the field moves from research and atlas-building toward clinical translation, including the need for scalable assays, standardized workflows, and rigorous validation.

 

The Future of Spatial Metabolomics in Cancer

The future of spatial metabolomics will likely involve greater integration with other technologies.

Potential developments include:

• Higher spatial resolution
• Improved metabolite identification
• Faster imaging
• Three-dimensional metabolic mapping
• Single-cell metabolomics
• Spatial multi-omics
• AI-assisted analysis
• Integration with digital pathology
• Longitudinal treatment studies
• Improved clinical workflows
• More standardized analytical pipelines

Another important direction is the integration of spatial metabolomics with patient-specific clinical information.

This could eventually allow researchers to connect metabolic landscapes with:

• Tumor stage
• Molecular subtype
• Treatment history
• Response
• Recurrence
• Survival
• Resistance mechanisms

However, these applications require substantial research and clinical validation.

 

Why Spatial Metabolomics Matters for Modern Cancer Research

Cancer biology is increasingly understood as a spatial and dynamic process.

A tumor is not simply a collection of genetically abnormal cells. It is an ecosystem in which cancer cells interact with immune cells, stromal cells, blood vessels, extracellular matrix, nutrients, metabolites, and signaling molecules.

Spatial metabolomics provides a way to investigate one of the most important components of this ecosystem: metabolic activity in its physical context.

By showing where metabolites are located, researchers can begin to connect metabolic pathways with tumor architecture, cellular interactions, immune responses, treatment resistance, and disease progression.

The combination of spatial metabolomics with spatial transcriptomics, spatial proteomics, imaging, pathology, and artificial intelligence could further expand the ability to understand cancer at multiple biological scales.

Conclusion

Spatial metabolomics in cancer is an emerging approach that combines metabolomics with spatial molecular mapping to reveal how metabolic processes are organized within tumors.

Unlike conventional metabolomics, which can provide an overall metabolic profile, spatial metabolomics preserves information about where metabolic changes occur.

This capability is particularly valuable for studying tumor heterogeneity, metabolic niches, tumor-microenvironment interactions, immune regulation, drug resistance, biomarker discovery, and precision oncology.

Mass spectrometry imaging technologies such as MALDI-MSI and DESI-MSI have played an important role in advancing spatial metabolomics research, while integration with single-cell technologies, spatial transcriptomics, proteomics, and AI is creating increasingly detailed molecular maps of cancer.

As analytical technologies mature and standardized workflows improve, spatial metabolomics may become an increasingly important research tool for understanding cancer biology and developing more precise approaches to cancer diagnosis, treatment, and monitoring.

 

Frequently Asked Questions (FAQs)

1. What is spatial metabolomics in cancer?

Spatial metabolomics in cancer is a research approach that maps the distribution of metabolites within tumor tissue while preserving spatial information. It helps researchers understand how metabolic activity varies across different regions of a tumor.

2. How is spatial metabolomics different from conventional metabolomics?

Conventional metabolomics generally measures metabolites from a biological sample, while spatial metabolomics provides information about both the metabolites and their locations within tissue.

3. What technology is commonly used for spatial metabolomics?

Mass spectrometry imaging (MSI) is one of the major technologies used for spatial metabolomics. MALDI-MSI and DESI-MSI are important platforms for spatial molecular analysis.

4. Why is spatial metabolomics important in cancer research?

It can help researchers investigate metabolic heterogeneity, tumor microenvironment interactions, metabolic niches, biomarkers, treatment resistance, and other biological processes that vary across tumor regions.

5. Can spatial metabolomics identify cancer biomarkers?

Spatial metabolomics can contribute to biomarker discovery by identifying metabolites or spatial metabolic patterns associated with specific tumor regions or biological characteristics. Candidate biomarkers still require independent validation before clinical use.

6. Can spatial metabolomics study the tumor microenvironment?

Yes. Spatial metabolomics can be used to investigate metabolic relationships among cancer cells, immune cells, fibroblasts, endothelial cells, and other components of the tumor microenvironment.

7. Can spatial metabolomics help understand cancer treatment resistance?

It may help researchers identify metabolic adaptations and spatial regions associated with treatment resistance. These findings could support research into mechanisms of resistance and potential therapeutic strategies.

8. Can spatial metabolomics be combined with spatial transcriptomics?

Yes. Combining spatial metabolomics with spatial transcriptomics can connect gene-expression patterns with metabolic activity within the same or related tissue regions.

9. What role can artificial intelligence play in spatial metabolomics?

AI and machine learning can assist with image analysis, spatial pattern recognition, metabolic-region classification, biomarker discovery, and integration of spatial metabolomics with other molecular datasets.

10. Is spatial metabolomics currently used routinely in cancer treatment?

Spatial metabolomics remains primarily a research and translational technology. Although clinical applications are being investigated, broader routine clinical adoption requires further validation, standardization, and development of practical workflows.

11. What cancers can be studied using spatial metabolomics?

Research applications include breast cancer, prostate cancer, colorectal cancer, liver cancer, lung cancer, brain tumors, and other malignancies. The specific application depends on the research question and available tissue and analytical technology.

12. What is the future of spatial metabolomics?

Future development is expected to focus on higher spatial resolution, improved metabolite identification, single-cell analysis, three-dimensional mapping, AI-assisted analysis, spatial multi-omics, and clinical translation.

 

About WCOCC-2026

The World Conference on Oncology & Cancer Care (WCOCC-2026) will bring together researchers, oncologists, healthcare professionals, scientists, clinicians, academics, and industry experts to discuss emerging developments across oncology and cancer care.

World Conference on Oncology & Cancer Care (WCOCC-2026)
November 19–21, 2026 | Tokyo, Japan

The conference provides an opportunity to share research, present new findings, exchange scientific knowledge, and discuss emerging technologies shaping the future of cancer diagnosis, treatment, and precision oncology.

Researchers and professionals working in cancer metabolism, metabolomics, spatial biology, precision oncology, tumor microenvironment research, cancer biomarkers, and related fields are encouraged to participate and share their work.